Baxter International (XSWX:BAX) Interest Expense : CHF-434 Mil (TTM As of Mar. 2024)

View and export this data going back to 1995. Start your Free Trial

What is Baxter International Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Baxter International's interest expense for the three months ended in Mar. 2024 was CHF -92 Mil. Its interest expense for the trailing twelve months (TTM) ended in Mar. 2024 was CHF-434 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Baxter International's Operating Income for the three months ended in Mar. 2024 was CHF 195 Mil. Baxter International's Interest Expense for the three months ended in Mar. 2024 was CHF -92 Mil. Baxter International's Interest Coverage for the quarter that ended in Mar. 2024 was 2.13. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Baxter International Interest Expense Historical Data

The historical data trend for Baxter International's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Baxter International Interest Expense Chart

Baxter International Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Interest Expense

Get a 7-Day Free Trial

-109.07

-135.93

-190.65

-386.61

-442.78

Baxter International Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Interest Expense	Get a 7-Day Free Trial															-117.54	-118.85	-122.35	-101.18	-91.53

Baxter International Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was CHF-434 Mil.

Baxter International (XSWX:BAX) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Baxter International's Interest Expense for the three months ended in Mar. 2024 was CHF-92 Mil. Its Operating Income for the three months ended in Mar. 2024 was CHF195 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Mar. 2024 was CHF10,251 Mil.

Baxter International's Interest Coverage for the quarter that ended in Mar. 2024 is calculated as

Interest Coverage	=	-1	*	Operating Income (Q: Mar. 2024 )	/	Interest Expense (Q: Mar. 2024 )
	=	-1	*	194.603	/	-91.526
	=	2.13

The higher the ratio, the stronger the company's financial strength is.

Baxter International (XSWX:BAX) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Baxter International Inc (XSWX:BAX) » Definitions » Interest Expense

Comparable Companies

Traded in Other Exchanges

BAX:USA 1BAX:Italy BTL:Germany BAX:Austria

Address

One Baxter Parkway, Deerfield, IL, USA, 60015

Website

https://www.baxter.com

Baxter offers a variety of medical instruments and supplies to caregivers. It enhanced its portfolio of hospital-focused offerings by acquiring Hillrom in late 2021, which added basic equipment, including hospital beds, to the portfolio, although about half of Hillrom's revenue comes from more digitally connected offerings like its smart beds and Voalte medical communications app. From its legacy operations, Baxter offers tools to help patients with acute and chronic kidney failure, which it plans to spin off by mid-2024. It also sells a variety of injectable therapies for use in care settings, such as IV pumps, administrative sets, and solutions; nutritional products; and surgical sealants and hemostatic agents.